In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea Passes EU Equivalence Assessment For APIs

Executive Summary

The European Commission took four years to evaluate South Korea's regulatory framework for active pharmaceutical ingredients and to conclude that it is in line with EU standards.

You may also be interested in...



Top 20 countries exporting APIs confirm plans to meet EU July deadline

Twelve of the top 20 countries that export active pharmaceutical ingredients (APIs) to the EU have confirmed they will issue written confirmations to certify that their consignments comply with EU good manufacturing practices (GMPs) 1.

Global Medtech Guidance Tracker: July 2020

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.

EU Pilot Facilitates Multilingual Packaging To Improve Medicines Availability

A six-month pilot has been launched in the EU to test new processes for multilingual packaging that allows the use of a reduced text on a medicine’s immediate and outer packaging, subject to agreement by member states.

Topics

UsernamePublicRestriction

Register

SC027449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel